Freight distribution with electric vehicles: A case study in Sicily. Delivery van development

Abstract A change in the logistics sector in terms of environmental sustainability is necessary to support the achievement of the social challenges associated with freight transport. Unfortunately, the policy responses to solving congestion and emissions issues are mainly dedicated to the movement of people. The most valued opportunities to reduce the negative effects of freight delivery (the goal of EU policy is CO2 free urban logistics by 2030) regards both the use of electric vehicles to perform the distribution and the introduction of distribution centres that encourage the use of light commercial vehicles. However, the combination of zero emission vehicles in logistic and transportation activities requires some additional challenges from the organizational and operational point of view. In order to avoid the delocalization of polluting emissions it is necessary that the production of electricity related to the new needs comes from renewable sources preferably distributed throughout the territory. This paper explores the integration of electric vehicles in logistics operations executed through light commercial vehicles, taking into consideration, during the design phase of a new concept delivery van, the technical connections with the production systems and its possible applications also in areas other than urban. The results of the case study presented encourage the development of a type of vehicle with features not yet covered by the market and which are of particular relevance for sustainable logistics applied to small towns or small islands, which are widespread in Italy

Freight distribution with electric vehicles: A case study in Sicily. RES, infrastructures and vehicle routing

Abstract This paper deals with the issue of the production of electricity required for an electric delivery van to carry out its daily mission. In particular, the technical solutions adopted for the generation and management of energy from renewable energy sources will be illustrated. Subsequently a vehicle routing problem with time windows is formulated in order to optimize the freight distribution at urban level completing the exploration of two aspects, infrastructures and management of the service, considered fundamental for dealing with the distribution of freight in a system scenario. The article describes a case study for the delivery of freight within the last mile in which the installation of renewable energy production plants is proposed in the same place where the urban distribution center has been planned. The area dedicated to freight handling is thus proposed in the work as an energy platform as well as logistics. The optimization of a freight delivery service is performed in order to reduce the energy used by the vehicle in its daily travels and some aspects related to the governance (i.e. time windows allowed for the delivery/pick-up operations) are included in the problem constraints. A test application, considering a set of 84 retailers, has been carried out as case study in the Capo d'Orlando municipality (Sicily, Italy)

dynamic simulation of a multi generation system for electric and cooling energy provision employing a sofc cogenerator and an adsorption chiller

Abstract Aim of this work is the dynamic simulation of the operation of a small-scale multi-generation system, based on a Solid Oxide Fuel Cell (SOFC) micro-cogenerator (μCHP) coupled to an adsorption chiller, to provide electric and cooling energy to a telecommunication shelter. The dynamic simulation model has been implemented in TRNSYS environment. The μCHP has nominal electric power of 2.5 kW and its thermal output is used to drive a thermally driven adsorption chiller, with nominal cooling power of 10 kW. The performance of both components were experimentally validated under controlled lab conditions. The developed model allowed to optimize the system configuration and to perform an energy and environmental analysis. This analysis demonstrated the possibility of achieving global energy efficiency up to 63% with a CO2 reduction proportional to the electric and cooling load of the telecommunication shelter

Antioxidant capacity of Rigenase®, a specific aqueous extract of triticum vulgare

Reactive species of oxygen (ROS), responsible for oxidative stress, accumulate in various tissues damaged by burns, decubitus ulcers, and vascular lesions. Antioxidants play an important and well-documented role in healing of chronic and acute wounds. Rigenase®, a specific extract of Triticum vulgare manufactured by Farmaceutici Damor, is employed in products used for the regeneration of tissue injuries. In this work, we show that Rigenase® exhibits a scavenging effect toward free radicals, thus pointing to its relevant antioxidant activity

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production

The ErbB2 blocker trastuzumab improves survival in oncologic patients, but can cause cardiotoxicity. The late Na+ current inhibitor ranolazine has been shown to counter experimental HF, including doxorubicin cardiotoxicity (a condition characterized by derangements in redox balance), by lowering the levels of reactive oxygen species (ROS). Since ErbB2 can modulate ROS signaling, we tested whether trastuzumab cardiotoxicity could be blunted by ranolazine via redox-mediated mechanisms. Trastuzumab decreased fractional shortening and ejection fraction in mice, but ranolazine prevented heart dysfunction when co-administered with trastuzumab. Trastuzumab cardiotoxicity was accompanied by elevations in natriuretic peptides and matrix metalloproteinase 2 (MMP2) mRNAs, which were not elevated with co-treatment with ranolazine. Trastuzumab also increased cleavage of caspase-3, indicating activation of the proapoptotic machinery. Again, ranolazine prevented this activation. Interestingly, Neonatal Rat Ventricular Myocytes (NRVMs), labeled with MitoTracker Red and treated with trastuzumab, showed only a small increase in ROS compared to baseline conditions. We then stressed trastuzumab-treated cells with the beta-agonist isoproterenol to increase workload, and we observed a significant increase of probe fluorescence, compared with cells treated with isoproterenol alone, reflecting induction of oxidative stress. These effects were blunted by ranolazine, supporting a role for INa inhibition in the regulation of redox balance also in trastuzumab cardiotoxicity

Development of a New Concept Electric Vehicle for Last Mile Transportations

Within European cities, where 68% of the EU population lives using 70% of the energy, an integrated and sustainable urban approach is needed. In order to meet the increasingly complex challenges of urban areas new, efficient, and user-friendly technologies and services, in particular in areas of energy, transport, and ICT are required. In the transport sector electric urban mobility and synergy between different transport systems (ITS) and infrastructures must be supported strongly in order to improve life conditions of citizens in terms of i) emissions, ii) services, iii) traffic congestion (an ambitious challenge is reduction of journey times). With the aim of improving the city logistic more efficient peopletransport and freight-distribution systems have to be used, so electro-mobility for transport in the “last mile” must be supported. In the i-NEXT (Innovation for greeN Energy and eXchange in Transportation) project, in which CNR ITAE is directly involved as coordinator, activities are addressed to implementation of new concept modular electric vehicles having different upper-bodies able to be used both for people (public transport) and freight in urban areas. The project aims to develop a not commercial vehicle characterized by new design in which the challenge is to reach the lowest ratio between total weight and load capacity (europallet for freight and seats for people). Other important aspects are to define specific mission of use, range of autonomy, recharge times and cost in terms of batteries and recharge systems technologies. In conclusion synergy of electro-mobility with renewable energy plants and smart grids is essential for sustainability of smart city concept. Document type: Articl

Postnatal growth in a cohort of Sardinian intrauterine growth-restricted infants

Recent studies have shown that infants with intrauterine growth restriction (IUGR) undergo catch-up growth during infancy. The aim of our study was to evaluate the postnatal growth in a cohort of IUGR infants born in a tertiary-level Obstetric University Hospital of Northern Sardinia. An observational retrospective study was conducted on 12 IUGR (group A) and 12 control infants (group B) by measuring the anthropometric parameters of weight (W), length (L) and head circumference (HC) from birth to the 3rd postnatal year. At birth, significant differences were found between group A and group B with regard to all the auxological parameters (W, mean 1846.6 versus 3170.8 g, p < 0.0001; HC, 30.1 versus 34.4 cm, p < 0.0001; L, mean 43.4 versus 49.4 cm, p < 0.0001). During the 1st year, 8 of 12 (70%) IUGR infants exhibited a significant catch-up growth in the 3 anthropometric parameters and a regular growth until the 3rd year of follow-up. The majority but not all infants born with IUGR in our series showed significant postnatal catch-up growth essentially during the first 12 months of life. An improved knowledge of the causes of IUGR will help to develop measures for its prevention and individualized treatment

Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production

The ErbB2 blocker trastuzumab improves survival in oncologic patients, but can cause cardiotoxicity. The late Na+ current inhibitor ranolazine has been shown to counter experimental HF, including doxorubicin cardiotoxicity (a condition characterized by derangements in redox balance), by lowering the levels of reactive oxygen species (ROS). Since ErbB2 can modulate ROS signaling, we tested whether trastuzumab cardiotoxicity could be blunted by ranolazine via redox-mediated mechanisms. Trastuzumab decreased fractional shortening and ejection fraction in mice, but ranolazine prevented heart dysfunction when co-administered with trastuzumab. Trastuzumab cardiotoxicity was accompanied by elevations in natriuretic peptides and matrix metalloproteinase 2 (MMP2) mRNAs, which were not elevated with co-treatment with ranolazine. Trastuzumab also increased cleavage of caspase-3, indicating activation of the proapoptotic machinery. Again, ranolazine prevented this activation. Interestingly, Neonatal Rat Ventricular Myocytes (NRVMs), labeled with MitoTracker Red and treated with trastuzumab, showed only a small increase in ROS compared to baseline conditions. We then stressed trastuzumab-treated cells with the beta-agonist isoproterenol to increase workload, and we observed a significant increase of probe fluorescence, compared with cells treated with isoproterenol alone, reflecting induction of oxidative stress. These effects were blunted by ranolazine, supporting a role for INa inhibition in the regulation of redox balance also in trastuzumab cardiotoxicity

Selective mitochondrial superoxide generation in vivo is cardioprotective through hormesis

Reactive oxygen species (ROS) have an equivocal role in myocardial ischaemia reperfusion injury. Within the cardiomyocyte, mitochondria are both a major source and target of ROS. We evaluate the effects of a selective, dose-dependent increase in mitochondrial ROS levels on cardiac physiology using the mitochondria-targeted redox cycler MitoParaquat (MitoPQ). Low levels of ROS decrease the susceptibility of neonatal rat ventricular myocytes (NRVMs) to anoxia/reoxygenation injury and also cause profound protection in an in vivo mouse model of ischaemia/reperfusion. However higher doses of MitoPQ resulted in a progressive alteration of intracellular [Ca2+] homeostasis and mitochondrial function in vitro, leading to dysfunction and death at high doses. Our data show that a primary increase in mitochondrial ROS can alter cellular function, and support a hormetic model in which low levels of ROS are cardioprotective while higher levels of ROS are cardiotoxic.The work is supported by an MRC Studentship to JFM and a Wellcome Trust Investigator award to RCH (110158/Z/15/Z), the Leducq Transatlantic Network of Excellence, and the University of Padova Strategico grant (FDL). Part of the study was funded by an MRC Project Grant to TK (MR/P000320/1). Michele Cariello is thanked for help with cyclic voltammetry